Fibrinogen Gamma Monoclonal Antibody

The protein encoded by this gene is the gamma component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia and thrombophilia. Alternative splicing results in transcript variants encoding different isoforms.

Introducing the Fibrinogen Gamma Monoclonal Antibody, a cutting-edge pharmaceutical innovation designed to revolutionize the field of medical research and diagnostics. This meticulously crafted product is meticulously engineered to target and bind specifically to the fibrinogen gamma chain, offering unprecedented accuracy and precision in detecting and analyzing fibrinogen gamma-related disorders.

Crafted with utmost care and adherence to stringent quality standards, this monoclonal antibody showcases exceptional specificity and affinity towards its target, ensuring reliable and reproducible results. Its advanced formulation guarantees minimal cross-reactivity, thereby minimizing the risk of false positives and false negatives, and enabling researchers and clinicians to confidently rely on its outcomes.

The Fibrinogen Gamma Monoclonal Antibody boasts an exceptional level of purity, meticulously purified and characterized to ensure the absence of any impurities or contaminants that may compromise its efficacy. This purity, combined with its high stability and long shelf life, guarantees consistent performance and longevity, making it an indispensable tool for laboratories and medical institutions alike.

Furthermore, this monoclonal antibody is conveniently available in various formats, including liquid and lyophilized forms, catering to diverse experimental requirements and facilitating ease of use. Its user-friendly nature allows for seamless integration into existing laboratory protocols, ensuring a hassle-free experience for researchers and clinicians.

In summary, the Fibrinogen Gamma Monoclonal Antibody represents a breakthrough in medical research and diagnostics, offering unparalleled specificity, reliability, and convenience. With its exceptional purity, stability, and versatility, this product is poised to redefine the standards of excellence in the field. Embrace the future of medical advancements with the Fibrinogen Gamma Monoclonal Antibody and unlock new possibilities in the realm of fibrinogen gamma-related disorders.